Beth du, MD
Internal Medicine · Richmond, VANPI 1639122245
Payments from drug & device makers
Across 131 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$668
- Novo Nordisk$262
- Amgen$204
- Pfizer$144
- AstraZeneca$125
- Abbott$109
- plus $734 from 28 others
What the payments were for
- Food & beverage$2,247100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $668 |
| Novo Nordisk | 17 | $262 |
| Amgen | 12 | $204 |
| Pfizer | 8 | $144 |
| AstraZeneca(2 entities) | 9 | $125 |
| Abbott | 6 | $109 |
| Lilly USA, LLC | 6 | $92 |
| GSK | 5 | $75 |
| Merck | 3 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Exact Sciences | 2 | $36 |
| Inspire Medical Systems, Inc. | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 1 | $29 |
| Boston Scientific | 1 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Dynavax Technologies Corporation | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Bayer | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Edwards Lifesciences | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Abiomed | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Almatica Pharma LLC | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $12 |
| Novartis | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
How this compares
$2,247 in reported general payments places this provider in the 85th percentile of 2,724 internal medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 37 | $38,002 |
| JanuviaSitagliptin Phosphate | 19 | $25,348 |
| OzempicSemaglutide | 19 | $24,338 |
| EliquisApixaban | 16 | $17,907 |
| FarxigaDapagliflozin Propanediol | 13 | $14,267 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $5,267 |
| Atorvastatin Calcium | 494 | $4,675 |
| Levothyroxine Sodium | 291 | $3,895 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $3,869 |
| Duloxetine Hcl | 95 | $3,390 |
| SynthroidLevothyroxine Sodium | 57 | $2,368 |
| Amlodipine Besylate | 264 | $1,824 |
| Lisinopril | 302 | $1,796 |
| Estradiol | 19 | $1,537 |
| Ipratropium Bromide | 27 | $1,310 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $44 | $25,34819 claims |
| Novo NordiskOzempic | $262 | $24,33819 claims |
| PfizerEliquis | $144 | $17,90716 claims |
| AstraZenecaFarxiga | $125 | $14,26713 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $3,895291 claims |
| AbbVieSynthroid | $668 | $2,36857 claims |
| Almatica Pharma LLCSertraline Hcl | $13 | $63866 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,724 internal medicine providers in Virginia.
Other internal medicine in Richmond
- Leroy VaughanRichmond$20.8M
- Andrew PoklepovicRichmond$4.6M
- Richard JacksonRichmond$2.5M
- Lawrence SchwartzRichmond$2.4M
- John HoekstraRichmond$344K
- Franklin ZieveRichmond$337K
- Wally SmithRichmond$333K
- Thokozeni LipatoRichmond$247K
- John BarrettRichmond$217K
- Alan DowRichmond$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.